Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Regenerative Medical Technology's operating income for the twelve months ending Jun 30, 2026 was $43.73K, down 84.7% year over year. For fiscal 2025 it was -$867.16K, down 1168.2% from the year before.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$867.16K | -1168.2% |
| FY2024 | Dec 31, 2024 | $81.18K | – |
| FY2023 | Dec 31, 2023 | -$715.23K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $565.98K | – |
| Q1 FY2026 | Mar 31, 2026 | $229.78K | +70.3% |
| Q4 FY2025 | Dec 31, 2025 | -$306.27K | -180.5% |
| Q3 FY2025 | Sep 30, 2025 | -$445.76K | -2368.7% |
| Q2 FY2025 | Jun 30, 2025 | -$250.09K | – |
| Q1 FY2025 | Mar 31, 2025 | $134.96K | – |
| Q4 FY2024 | Dec 31, 2024 | $380.62K | – |
| Q3 FY2024 | Sep 30, 2024 | $19.65K | – |
| Q2 FY2024 | Jun 30, 2024 | -$213.98K | – |
| Q1 FY2024 | Mar 31, 2024 | -$105.11K | – |
See a number that looks wrong?